PepFellas Laboratories | Research-Grade Peptides
PEPFELLAS Laboratories • Est. 2026
Research Wiki / Peptide Profile
Peptide Profile

Melanotan II (MT-II)

Melanotan II (MT-II) is a synthetic, cyclic heptapeptide analogue of endogenous alpha-melanocyte-stimulating hormone ($\alpha$-MSH). It is a potent, non-selective melanocortin receptor agonist researched for melanogenesis, central sexual arousal, and appetite suppression.

1. Chemical Structure and Biochemistry

Melanotan II is a shortened, cyclic lactam derivative of $\alpha$-MSH designed for enhanced receptor binding affinity and resistance to enzymatic proteolysis.

  • Peptide Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-$\text{NH}_2$
  • Structural Modification: Incorporating a lactam bridge between the aspartic acid and lysine side chains locks the peptide into a stable cyclic conformation, while the D-phenylalanine substitution drastically increases its biological potency relative to native $\alpha$-MSH.

2. Mechanism of Action

MT-II acts as a non-selective agonist across multiple melanocortin receptor subtypes (MC1R, MC3R, MC4R, and MC5R).

  • Melanogenesis (MC1R): Activation of MC1R on epidermal melanocytes stimulates cAMP signaling and tyrosinase activity, increasing eumelanin production and skin pigmentation without UV exposure.
  • Central Sexual Function & Appetite (MC3R / MC4R): Because MT-II crosses the blood-brain barrier, activation of hypothalamic MC4R and MC3R pathways triggers central erectile/libido signaling and suppresses appetite.

3. Research and Applications

While clinical development of MT-II itself was discontinued due to its broad, non-selective side-effect profile (such as nausea, flushing, and spontaneous erections), it directly spawned approved pharmaceutical derivatives.

  • Photoprotection & Dermatology: Studied for inducing protective eumelanin tanning in fair-skinned individuals susceptible to UV-induced DNA damage.
  • Neuroendocrinology & Sexual Dysfunction: Its central pro-erectile effects led to the isolation of its metabolite/derivative, Bremelanotide (PT-141), which was later FDA-approved for hypoactive sexual desire disorder (HSDD).

Note: Melanotan II is an unapproved experimental chemical and is not authorized for human therapeutic or cosmetic use by the FDA or EMA.

Tags: Melanotan-II MT-II alpha-MSH-analogue cyclic-heptapeptide melanocortin-receptor-agonist MC1R MC4R melanogenesis eumelanin photoprotection